NCT07032506 Intrauterine Stent Placement Following Hysteroscopic Septum Resection
| NCT ID | NCT07032506 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Weill Medical College of Cornell University |
| Condition | Intrauterine Adhesion |
| Study Type | INTERVENTIONAL |
| Enrollment | 320 participants |
| Start Date | 2026-05-14 |
| Primary Completion | 2029-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 320 participants in total. It began in 2026-05-14 with a primary completion date of 2029-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study hopes to learn the best way to prevent internal scar tissue after septum removal. The use of an intrauterine foley catheter balloon may prevent the formation of adhesions following surgery.
Eligibility Criteria
Inclusion Criteria: * Age 18 and above * Patients electing to undergo hysteroscopic septoplasty following an informed consent and shared decision making process * Uterine septum of at least 50% of the uterine cavity length as quantified on 3-dimensional saline infusion ultrasound Exclusion Criteria: * Unwilling or unable to provide informed consent * History of prior uterine septum resection * History of prior transmural uterine surgery * Preexisting intrauterine adhesions or prior treatment for intrauterine adhesions * Individuals in whom complete septum resection is unable to be performed as a single procedure
Contact & Investigator
Glenn Schattman, MD
PRINCIPAL INVESTIGATOR
Weill Medical College of Cornell University
Frequently Asked Questions
Who can join the NCT07032506 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Intrauterine Adhesion. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07032506 currently recruiting?
Yes, NCT07032506 is actively recruiting participants. Contact the research team at res2011@med.cornell.edu for enrollment information.
Where is the NCT07032506 trial being conducted?
This trial is being conducted at Little Rock, United States, New York, United States, Cleveland, United States.
Who is sponsoring the NCT07032506 clinical trial?
NCT07032506 is sponsored by Weill Medical College of Cornell University. The principal investigator is Glenn Schattman, MD at Weill Medical College of Cornell University. The trial plans to enroll 320 participants.